| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALHC | Common Stock | Sale | -$318K | -24K | -4.22% | $13.23 | 545K | Nov 1, 2022 | See Footnote | F1, F2, F3 |
| holding | ALHC | Common Stock | 731K | Nov 1, 2022 | Direct |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. |
| F2 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.10 to $13.38. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
| F3 | Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. |